CPE Credit 2022

Individual Courses

1.25 contact hours: May 19th, 2022: 1:00-2:15pm (EST): “Effects of THC and CBD: Implications for Future Clinical Trials”- Dr. Kent Hutchison, Ph.D.; Professor of Psychiatry, Anschutz Medical Campus; Adjunct Professor of Psychology and Neuroscience, University of Colorado in Boulder

  • UAN: 0012-0000-22-017-L99-P
  • At the completion of this activity, the participant will be able to:
    • Describe the psychoactive and physiological effects of THC and CBD
    • Explain the dosages for THC and CBD to render effect while minimizing potential for adverse events
    • Identify differences in dosages of THC and CBD that are typically deployed within clinical trials and how these may differ from dosages used by patients in real-world settings

1.25 contact hours: May 19th, 2022: 9:30-10:45am (EST): “Clarifying Cannabis: Considering the impact of recreational and medical use on cognitive and clinical outcomes”- Dr. Staci Gruber, Ph.D.;  Director, Cognitive and Clinical Neuroimaging Core, McLean Hospital; Director, Marijuana Investigations for Neuroscience Discovery (MIND), McLean Hospital; Associate Professor of Psychiatry, Harvard Medical School

  • UAN: 0012-0000-22-018-L99-P
  • At the completion of this activity, the participant will be able to:
    • Describe the impact of medical marijuana on cognition and other clinically relevant indicators of cognitive performance
    • Describe the impact of marijuana from nonmedical sources on cognition
    • Identify potential neuropsychiatric and cognitive performance-related adverse events associated with marijuana use

1.25 contact hours: May 20th, 2022: 8:15-9:30am (EST): “Cannabis Use in Pain and as a Substitute for Opioids”- Dr. Samer Narouze, MD, Ph.D.; Associate Professor of Surgery, Northeast Ohio Medical University; Clinical Professor of Anesthesiology and Neurological Surgery, Ohio State University College of Medicine; President, American Society of Regional Anesthesia and Pain Medicine; Chairman, American Interventional Headache Society (AIHS)

  • UAN: 0012-0000-22-019-L99-P
  • At the completion of this activity, the participant will be able to:
    • Describe how cannabinoids have been used for the treatment of pain
    • Explain efficacy of adjuvant pain treatment between different cannabinoids as compared with pharmacotherapy pain treatments
    • Identify potential adverse events of cannabinoids deployed within adjuvant pain treatment

All Other Program Information

  • Type of Activity: Knowledge
  • Schedule of educational activity: Introductions, presentation, question and answer session
  • Target Audience: Pharmacists

Continuing Education Accreditation

The University of Florida is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The University of Florida College of Pharmacy will report continuing education credit to CPE Monitor within 60 days following the activity. For pharmacists registered in Florida, credit will also be reported to CE Broker.

  • Requirements for successful completion: Participants must attend the entire program and complete an online evaluation to receive credit.
  • Program Support: No program support was provided for this activity.
  • Fee(s) for participation: There is no fee associated with this program


Event Search